article thumbnail

Tachyarrhythmias in congenital heart disease

Frontiers in Cardiovascular Medicine

The prevalence of congenital heart disease (CHD) in adult patients has risen with advances in diagnostic and surgical techniques. Patients with CHD commonly experience both supraventricular and ventricular arrhythmias, with each CHD type associated with different arrhythmia patterns.

article thumbnail

Challenges and opportunities in patients with adult congenital heart disease, a narrative review

Frontiers in Cardiovascular Medicine

Adult congenital heart disease Pregnancy Transition of care Challenges heart failure.

article thumbnail

Heart organoids simulate pregestational diabetes-induced congenital heart disease

Science Daily - Heart Disease

An advanced human heart organoid system can be used to model embryonic heart development under pregestational diabetes-like conditions, researchers report. The organoids recapitulate hallmarks of pregestational diabetes-induced congenital heart disease found in mice and humans.

article thumbnail

Latest research redefines neurodevelopmental risks, outcomes for congenital heart disease

American Heart News - Heart News

Statement Highlights: A new American Heart Association scientific statement updates more than a decade of research identifying, managing and preventing neurodevelopmental delays and disorders among people with congenital heart disease.

article thumbnail

Exercise and Sports Participation in Complex Congenital Heart Disease in Teenagers and Adults

American College of Cardiology

Developments in cardiovascular (CV) surgery and related care have led to the improved survival of patients with congenital heart disease (CHD) and more teenagers and adults living with congenital heart disease (ACHD).

article thumbnail

Advanced magnetic resonance imaging in human placenta: insights into fetal growth restriction and congenital heart disease

Frontiers in Cardiovascular Medicine

It will also discuss the clinical applications of MRI in diagnosing and monitoring placental insufficiency, as well as its implications for fetal growth restriction (FGR) and congenital heart disease (CHD).

article thumbnail

An Update on Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease

American College of Cardiology

addressed the safety, tolerability, and outcomes of patients with adult congenital heart disease (ACHD) treated with sodium-glucose cotransporter 2 inhibitors (SGLT2i). Neijenhuis et al. and Fusco et al.